Quick Summary:
In the dynamic and ever-evolving domain of healthcare, staying abreast of the latest market trends in key areas such as diagnostic testing is essential. For leaders and decision-makers in the field, our comprehensive market research report on the Global Viral Hepatitis and Retrovirus Diagnostic Tests encapsulates hard data, strategic insights, and profound analysis, offering a valued asset for those looking to navigate this burgeoning market.
Predicted to achieve an impressive rise from US$4 Billion in 2022 to an envisaged US$7.7 Billion by 2030, the market potential underlines the demand for such diagnostic tests and highlights the space for growth and investment. With market prospects in regions such as the U.S., China, Japan, Canada, and Germany minutely dissected, the report charts out the trajectory for the industry in the coming years. Get access not just to the data archives and bespoke updates, but also insights into the strategies employed by select competitors, assisting you in charting your organization's way forward. Dive into this fast-growing market with our extensive, data-driven report to steer your business decisions confidently.
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $7.7 Billion by 2030
The global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$4 Billion in the year 2022, is projected to reach a revised size of US$7.7 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2022-2030.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 11.4% CAGR
The Viral Hepatitis and Retrovirus Diagnostic Tests market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.Select Competitors (Total 31 Featured) -
- Abbott Diagnostics
- Amkay Products
- AOV International
- Apothecaries Sundries Manufacturing
- BD
- Beckman Coulter
- Bhat Bio-tech
- BioMerieux
- Bioneovan
- Bio-Rad
- Cepheid
- Chembio
- DiaSorin
- Enzo Biochem
- Fujirebio
- Gemc Technology
- Grifols
- Hangzhou Deangel Biological Engineering
- Hangzhou Heo Bio-Tech
- Hologic
- Horiba
- Innovation Biotech
- Jaksh Enterprises
- Krishco Medical Products
- Roche Diagnostics
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Viral Hepatitis and Retrovirus Diagnostic Tests?
What is the growth rate of the Global Market for Viral Hepatitis and Retrovirus Diagnostic Tests?
What is the forecasted size of the Global Market for Viral Hepatitis and Retrovirus Diagnostic Tests?
Who are the key companies in the Global Market for Viral Hepatitis and Retrovirus Diagnostic Tests?
Report Attribute | Details |
---|---|
No. of Pages | 168 |
Published | December 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4 Billion |
Forecasted Market Value ( USD | $ 7.7 Billion |
Compound Annual Growth Rate | 8.5% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Diagnostics
- Amkay Products
- AOV International
- Apothecaries Sundries Manufacturing
- BD
- Beckman Coulter
- Bhat Bio-tech
- BioMerieux
- Bioneovan
- Bio-Rad
- Cepheid
- Chembio
- DiaSorin
- Enzo Biochem
- Fujirebio
- Gemc Technology
- Grifols
- Hangzhou Deangel Biological Engineering
- Hangzhou Heo Bio-Tech
- Hologic
- Horiba
- Innovation Biotech
- Jaksh Enterprises
- Krishco Medical Products
- Roche Diagnostics